Page 18

Loading...
Tips: Click on articles from page
Page 18 1,021 views, 0 comment Write your comment | Print | Download

Minneapolis, MN—Donaldson Company, Inc., a global provider of filtration products and solutions, recently announced that it has acquired Solaris Biotechnology Srl.

Solaris designs and manufactures bioprocessing equipment, including bioreactors, fermenters and tangential flow filtration systems for use in food and beverage, biotechnology and other life sciences markets.

Solaris Biotechnology’s product portfolio ranges from benchtop systems for research and development facilities to pilot and commercialscale manufacturing systems, the company said.

Solaris was founded in 2002 and is headquartered in Porto Mantovano, Italy, with US operations based in Berkeley, CA.

“We are excited about Solaris’ capabilities and growth trajectory, and this acquisition is an important step on our journey towards strengthening our presence in the life sciences market,” said Tod Carpenter, chairman, president and chief executive officer of Donaldson. “With Solaris, we are well-postioned to provide more comprehensive solutions to food and beverage customers and expand our access to biopharma and other key life sciences markets.”

“By being part of Donaldson, we will have the global scale and financial flexibility to continue delivering on our growth plans, and we are thrilled about this opportunity,” said Matteo Brognoli, cofounder and chief executive officer of Solaris, who will remain with the company to lead Solaris as managing director.

“Like Donaldson, Solaris is built on strong customer relationships and providing technologically advanced solutions,” Brognoli said. “With the need for Solaris products expanding rapidly we are better able to meet the growing need while playing an important role in Donaldson’s expansion into life sciences.”

For more information, visit www.donaldson.com.

See also